Biosensing

Development of a clinical immunosensor based on SPR and fluorescence.

TOC ACS sensors (Letter_Charbonneau et al)

Charbonneau DM, Breault-Turcot J, Sinnett D, Krajinovic M, Leclerc J-M, Masson JF, Pelletier JN*, Tracking silent hypersensitivity reactions to asparaginase during leukemia therapy using indirect plasmonic and fluorescence immunosensing, (In preparation)

 

ao-2017-00110u_0006

Charbonneau DM, Aubé A, Rachel NM, Guerrero V, Delorme K, Breault-Turcot J, Masson JF, Pelletier JN*, Development of E. coli asparaginase II for immunosensing: A trade-off between receptor density and sensing efficiencyACS Omega. 2017, 2 (5), 2114–2125

 

se-2016-005319_0007

Aubé A, Charbonneau DM, Pelletier JN, Masson JF*, Response monitoring of acute lymphoblastic leukemia patients undergoing L‐Asparaginase therapy: successes and challenges associated with clinical sample analysis in plasmonic sensingACS Sensors. 2016, 1, 1358-1365